APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Immune Health Ingredient

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Immune Health Ingredient Market Outlook and Growth Opportunities 2026

Report ID 174001930422 December 2025206 pages

Choose your research edition.

Industry ResearchImmune Health Ingredient Industry Research Report 2026144 pages · $2,950 USDIndustry Growth & TrendsGlobal Immune Health Ingredient Industry Growth and Trends Forecast to 2032120 pages · $3,450 USDMarket StructureGlobal Immune Health Ingredient Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Immune Health Ingredient Market Outlook and Growth Opportunities 2026206 pages · $4,250 USDMarket Analysis & ForecastGlobal Immune Health Ingredient Market Analysis and Forecast 2026-2032200 pages · $4,950 USD

Market perspective

The global Immune Health Ingredient market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Immune Health Ingredient is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Immune Health Ingredient is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Immune Health Ingredient is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Immune Health Ingredient market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Immune Health Ingredient market include ADM, Arla Foods, Associated British Foods, Balchem, Cargill, Chr. Hansen, Divis Laboratories, DSM and Glanbia PLC, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Immune Health Ingredient market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Immune Health Ingredient and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Immune Health Ingredient sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Immune Health Ingredient market size, projected growth trends, production technologies, key applications, and end-use industries.

Immune Health Ingredient Segment by Company

ADM

Arla Foods

Associated British Foods

Balchem

Cargill

Chr. Hansen

Divis Laboratories

DSM

Glanbia PLC

Ingredion

International Flavors & Fragrances

Kerry Group PLC

MartinBauer

Roquette

ROYAL FRIESLANDCAMPINA N.V.

Tate & Lyle

BASF

Fonterra

Lonza

Probi

Immune Health Ingredient Segment by Type

Plant & Fruit Extracts

Nutritional Lipids

Prebiotics

Probiotic Starter Cultures

Vitamins

Minerals

Enzymes

Functional Carbohydrates

Proteins

Immune Health Ingredient Segment by Application

Beverages

Pharmaceuticals

Feed

Food

Others

Immune Health Ingredient Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Immune Health Ingredient status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Immune Health Ingredient market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Immune Health Ingredient significant trends, drivers, influence factors in global and regions.

6. To analyze Immune Health Ingredient competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Immune Health Ingredient market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Immune Health Ingredient and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Immune Health Ingredient.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Immune Health Ingredient market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Immune Health Ingredient industry.

Chapter 3: Detailed analysis of Immune Health Ingredient manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Immune Health Ingredient in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Immune Health Ingredient in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Immune Health Ingredient Industry Trends Table 2. Immune Health Ingredient Industry Drivers Table 3. Immune Health Ingredient Industry Opportunities and Challenges Table 4. Immune Health Ingredient Industry Restraints Table 5. Global Immune Health Ingredient Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Immune Health Ingredient Revenue Share by Company (2021-2026) Table 7. Global Immune Health Ingredient Sales Volume by Company (k units) & (2021-2026) Table 8. Global Immune Health Ingredient Sales Volume Share by Company (2021-2026) Table 9. Global Immune Health Ingredient Average Price (US$/unit) of Company (2021-2026) Table 10. Global Immune Health Ingredient Company Ranking, (2024-2026) & (USD Million) Table 11. Global Immune Health Ingredient Key Company Manufacturing Base & Headquarters Table 12. Global Immune Health Ingredient Company, Product Type & Application Table 13. Global Immune Health Ingredient Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Immune Health Ingredient by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Plant & Fruit Extracts Table 18. Significant Companies of Nutritional Lipids Table 19. Significant Companies of Prebiotics Table 20. Significant Companies of Probiotic Starter Cultures Table 21. Significant Companies of Vitamins Table 22. Significant Companies of Minerals Table 23. Significant Companies of Enzymes Table 24. Significant Companies of Functional Carbohydrates Table 25. Significant Companies of Proteins Table 26. Global Immune Health Ingredient Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 27. Global Immune Health Ingredient Sales Volume by Type (2021-2026) & (k units) Table 28. Global Immune Health Ingredient Sales Volume by Type (2027-2032) & (k units) Table 29. Global Immune Health Ingredient Sales Volume Share by Type (2021-2026) Table 30. Global Immune Health Ingredient Sales Volume Share by Type (2027-2032) Table 31. Global Immune Health Ingredient Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Immune Health Ingredient Sales Value by Type (2021-2026) & (US$ Million) Table 33. Global Immune Health Ingredient Sales Value by Type (2027-2032) & (US$ Million) Table 34. Global Immune Health Ingredient Sales Value Share by Type (2021-2026) Table 35. Global Immune Health Ingredient Sales Value Share by Type (2027-2032) Table 36. Significant Companies of Beverages Table 37. Significant Companies of Pharmaceuticals Table 38. Significant Companies of Feed Table 39. Significant Companies of Food Table 40. Significant Companies of Others Table 41. Global Immune Health Ingredient Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 42. Global Immune Health Ingredient Sales Volume by Application (2021-2026) & (k units) Table 43. Global Immune Health Ingredient Sales Volume by Application (2027-2032) & (k units) Table 44. Global Immune Health Ingredient Sales Volume Share by Application (2021-2026) Table 45. Global Immune Health Ingredient Sales Volume Share by Application (2027-2032) Table 46. Global Immune Health Ingredient Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Immune Health Ingredient Sales Value by Application (2021-2026) & (US$ Million) Table 48. Global Immune Health Ingredient Sales Value by Application (2027-2032) & (US$ Million) Table 49. Global Immune Health Ingredient Sales Value Share by Application (2021-2026) Table 50. Global Immune Health Ingredient Sales Value Share by Application (2027-2032) Table 51. Global Immune Health Ingredient Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 52. Global Immune Health Ingredient Sales by Region (2021-2026) & (k units) Table 53. Global Immune Health Ingredient Sales Market Share by Region (2021-2026) Table 54. Global Immune Health Ingredient Sales by Region (2027-2032) & (k units) Table 55. Global Immune Health Ingredient Sales Market Share by Region (2027-2032) Table 56. Global Immune Health Ingredient Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Immune Health Ingredient Sales Value by Region (2021-2026) & (US$ Million) Table 58. Global Immune Health Ingredient Sales Value Share by Region (2021-2026) Table 59. Global Immune Health Ingredient Sales Value by Region (2027-2032) & (US$ Million) Table 60. Global Immune Health Ingredient Sales Value Share by Region (2027-2032) Table 61. Global Immune Health Ingredient Market Average Price (US$/unit) by Region (2021-2026) Table 62. Global Immune Health Ingredient Market Average Price (US$/unit) by Region (2027-2032) Table 63. Global Immune Health Ingredient Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 64. Global Immune Health Ingredient Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 65. Global Immune Health Ingredient Sales by Country (2021-2026) & (k units) Table 66. Global Immune Health Ingredient Sales Market Share by Country (2021-2026) Table 67. Global Immune Health Ingredient Sales by Country (2027-2032) & (k units) Table 68. Global Immune Health Ingredient Sales Market Share by Country (2027-2032) Table 69. Global Immune Health Ingredient Sales Value by Country (2021-2026) & (US$ Million) Table 70. Global Immune Health Ingredient Sales Value Market Share by Country (2021-2026) Table 71. Global Immune Health Ingredient Sales Value by Country (2027-2032) & (US$ Million) Table 72. Global Immune Health Ingredient Sales Value Market Share by Country (2027-2032) Table 73. ADM Company Information Table 74. ADM Business Overview Table 75. ADM Immune Health Ingredient Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. ADM Immune Health Ingredient Product Portfolio Table 77. ADM Recent Development Table 78. Arla Foods Company Information Table 79. Arla Foods Business Overview Table 80. Arla Foods Immune Health Ingredient Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. Arla Foods Immune Health Ingredient Product Portfolio Table 82. Arla Foods Recent Development Table 83. Associated British Foods Company Information Table 84. Associated British Foods Business Overview Table 85. Associated British Foods Immune Health Ingredient Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. Associated British Foods Immune Health Ingredient Product Portfolio Table 87. Associated British Foods Recent Development Table 88. Balchem Company Information Table 89. Balchem Business Overview Table 90. Balchem Immune Health Ingredient Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. Balchem Immune Health Ingredient Product Portfolio Table 92. Balchem Recent Development Table 93. Cargill Company Information Table 94. Cargill Business Overview Table 95. Cargill Immune Health Ingredient Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 96. Cargill Immune Health Ingredient Product Portfolio Table 97. Cargill Recent Development Table 98. Chr. Hansen Company Information Table 99. Chr. Hansen Business Overview Table 100. Chr. Hansen Immune Health Ingredient Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 101. Chr. Hansen Immune Health Ingredient Product Portfolio Table 102. Chr. Hansen Recent Development Table 103. Divis Laboratories Company Information Table 104. Divis Laboratories Business Overview Table 105. Divis Laboratories Immune Health Ingredient Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 106. Divis Laboratories Immune Health Ingredient Product Portfolio Table 107. Divis Laboratories Recent Development Table 108. DSM Company Information Table 109. DSM Business Overview Table 110. DSM Immune Health Ingredient Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 111. DSM Immune Health Ingredient Product Portfolio Table 112. DSM Recent Development Table 113. Glanbia PLC Company Information Table 114. Glanbia PLC Business Overview Table 115. Glanbia PLC Immune Health Ingredient Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 116. Glanbia PLC Immune Health Ingredient Product Portfolio Table 117. Glanbia PLC Recent Development Table 118. Ingredion Company Information Table 119. Ingredion Business Overview Table 120. Ingredion Immune Health Ingredient Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 121. Ingredion Immune Health Ingredient Product Portfolio Table 122. Ingredion Recent Development Table 123. International Flavors & Fragrances Company Information Table 124. International Flavors & Fragrances Business Overview Table 125. International Flavors & Fragrances Immune Health Ingredient Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 126. International Flavors & Fragrances Immune Health Ingredient Product Portfolio Table 127. International Flavors & Fragrances Recent Development Table 128. Kerry Group PLC Company Information Table 129. Kerry Group PLC Business Overview Table 130. Kerry Group PLC Immune Health Ingredient Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 131. Kerry Group PLC Immune Health Ingredient Product Portfolio Table 132. Kerry Group PLC Recent Development Table 133. MartinBauer Company Information Table 134. MartinBauer Business Overview Table 135. MartinBauer Immune Health Ingredient Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 136. MartinBauer Immune Health Ingredient Product Portfolio Table 137. MartinBauer Recent Development Table 138. Roquette Company Information Table 139. Roquette Business Overview Table 140. Roquette Immune Health Ingredient Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 141. Roquette Immune Health Ingredient Product Portfolio Table 142. Roquette Recent Development Table 143. ROYAL FRIESLANDCAMPINA N.V. Company Information Table 144. ROYAL FRIESLANDCAMPINA N.V. Business Overview Table 145. ROYAL FRIESLANDCAMPINA N.V. Immune Health Ingredient Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 146. ROYAL FRIESLANDCAMPINA N.V. Immune Health Ingredient Product Portfolio Table 147. ROYAL FRIESLANDCAMPINA N.V. Recent Development Table 148. Tate & Lyle Company Information Table 149. Tate & Lyle Business Overview Table 150. Tate & Lyle Immune Health Ingredient Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 151. Tate & Lyle Immune Health Ingredient Product Portfolio Table 152. Tate & Lyle Recent Development Table 153. BASF Company Information Table 154. BASF Business Overview Table 155. BASF Immune Health Ingredient Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 156. BASF Immune Health Ingredient Product Portfolio Table 157. BASF Recent Development Table 158. Fonterra Company Information Table 159. Fonterra Business Overview Table 160. Fonterra Immune Health Ingredient Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 161. Fonterra Immune Health Ingredient Product Portfolio Table 162. Fonterra Recent Development Table 163. Lonza Company Information Table 164. Lonza Business Overview Table 165. Lonza Immune Health Ingredient Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 166. Lonza Immune Health Ingredient Product Portfolio Table 167. Lonza Recent Development Table 168. Probi Company Information Table 169. Probi Business Overview Table 170. Probi Immune Health Ingredient Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 171. Probi Immune Health Ingredient Product Portfolio Table 172. Probi Recent Development Table 173. Key Raw Materials Table 174. Raw Materials Key Suppliers Table 175. Immune Health Ingredient Distributors List Table 176. Immune Health Ingredient Customers List Table 177. Research Programs/Design for This Report Table 178. Authors List of This Report Table 179. Secondary Sources Table 180. Primary Sources List of Figures Figure 1. Immune Health Ingredient Product Image Figure 2. Global Immune Health Ingredient Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Immune Health Ingredient Sales Value (2021-2032) & (US$ Million) Figure 4. Global Immune Health Ingredient Sales (2021-2032) & (k units) Figure 5. Global Immune Health Ingredient Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Immune Health Ingredient Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Plant & Fruit Extracts Image Figure 10. Nutritional Lipids Image Figure 11. Prebiotics Image Figure 12. Probiotic Starter Cultures Image Figure 13. Vitamins Image Figure 14. Minerals Image Figure 15. Enzymes Image Figure 16. Functional Carbohydrates Image Figure 17. Proteins Image Figure 18. Global Immune Health Ingredient Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 19. Global Immune Health Ingredient Sales Volume Share 2021 VS 2025 VS 2032 Figure 20. Global Immune Health Ingredient Sales Volume Share by Type (2021-2032) Figure 21. Global Immune Health Ingredient Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Immune Health Ingredient Sales Value Share 2021 VS 2025 VS 2032 Figure 23. Global Immune Health Ingredient Sales Value Share by Type (2021-2032) Figure 24. Beverages Image Figure 25. Pharmaceuticals Image Figure 26. Feed Image Figure 27. Food Image Figure 28. Others Image Figure 29. Global Immune Health Ingredient Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 30. Global Immune Health Ingredient Sales Volume Share 2021 VS 2025 VS 2032 Figure 31. Global Immune Health Ingredient Sales Volume Share by Application (2021-2032) Figure 32. Global Immune Health Ingredient Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Immune Health Ingredient Sales Value Share 2021 VS 2025 VS 2032 Figure 34. Global Immune Health Ingredient Sales Value Share by Application (2021-2032) Figure 35. Global Immune Health Ingredient Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 36. Global Immune Health Ingredient Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 37. Global Immune Health Ingredient Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 38. Global Immune Health Ingredient Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 39. North America Immune Health Ingredient Sales Value (2021-2032) & (US$ Million) Figure 40. North America Immune Health Ingredient Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Europe Immune Health Ingredient Sales Value (2021-2032) & (US$ Million) Figure 42. Europe Immune Health Ingredient Sales Value Share by Country (%), 2025 VS 2032 Figure 43. Asia-Pacific Immune Health Ingredient Sales Value (2021-2032) & (US$ Million) Figure 44. Asia-Pacific Immune Health Ingredient Sales Value Share by Country (%), 2025 VS 2032 Figure 45. South America Immune Health Ingredient Sales Value (2021-2032) & (US$ Million) Figure 46. South America Immune Health Ingredient Sales Value Share by Country (%), 2025 VS 2032 Figure 47. Middle East & Africa Immune Health Ingredient Sales Value (2021-2032) & (US$ Million) Figure 48. Middle East & Africa Immune Health Ingredient Sales Value Share by Country (%), 2025 VS 2032 Figure 49. USA Immune Health Ingredient Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. USA Immune Health Ingredient Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. USA Immune Health Ingredient Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Canada Immune Health Ingredient Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Canada Immune Health Ingredient Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Canada Immune Health Ingredient Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Mexico Immune Health Ingredient Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Mexico Immune Health Ingredient Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Mexico Immune Health Ingredient Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Germany Immune Health Ingredient Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Germany Immune Health Ingredient Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Germany Immune Health Ingredient Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. France Immune Health Ingredient Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. France Immune Health Ingredient Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. France Immune Health Ingredient Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. U.K. Immune Health Ingredient Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. U.K. Immune Health Ingredient Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. U.K. Immune Health Ingredient Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Italy Immune Health Ingredient Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Italy Immune Health Ingredient Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Italy Immune Health Ingredient Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Spain Immune Health Ingredient Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Spain Immune Health Ingredient Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Spain Immune Health Ingredient Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Russia Immune Health Ingredient Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Russia Immune Health Ingredient Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Russia Immune Health Ingredient Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Netherlands Immune Health Ingredient Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Netherlands Immune Health Ingredient Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Netherlands Immune Health Ingredient Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Nordic Countries Immune Health Ingredient Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Nordic Countries Immune Health Ingredient Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Nordic Countries Immune Health Ingredient Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. China Immune Health Ingredient Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. China Immune Health Ingredient Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. China Immune Health Ingredient Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Japan Immune Health Ingredient Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Japan Immune Health Ingredient Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Japan Immune Health Ingredient Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. South Korea Immune Health Ingredient Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. South Korea Immune Health Ingredient Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. South Korea Immune Health Ingredient Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. India Immune Health Ingredient Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. India Immune Health Ingredient Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. India Immune Health Ingredient Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Australia Immune Health Ingredient Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Australia Immune Health Ingredient Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Australia Immune Health Ingredient Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Southeast Asia Immune Health Ingredient Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Southeast Asia Immune Health Ingredient Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Southeast Asia Immune Health Ingredient Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Brazil Immune Health Ingredient Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Brazil Immune Health Ingredient Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Brazil Immune Health Ingredient Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Argentina Immune Health Ingredient Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Argentina Immune Health Ingredient Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Argentina Immune Health Ingredient Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Chile Immune Health Ingredient Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Chile Immune Health Ingredient Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Chile Immune Health Ingredient Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Colombia Immune Health Ingredient Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Colombia Immune Health Ingredient Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Colombia Immune Health Ingredient Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Peru Immune Health Ingredient Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Peru Immune Health Ingredient Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Peru Immune Health Ingredient Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Saudi Arabia Immune Health Ingredient Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Saudi Arabia Immune Health Ingredient Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Saudi Arabia Immune Health Ingredient Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Israel Immune Health Ingredient Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Israel Arabia Immune Health Ingredient Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Israel Arabia Immune Health Ingredient Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. UAE Immune Health Ingredient Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. UAE Immune Health Ingredient Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. UAE Immune Health Ingredient Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Turkey Immune Health Ingredient Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Turkey Immune Health Ingredient Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Turkey Immune Health Ingredient Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. Iran Immune Health Ingredient Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 128. Iran Immune Health Ingredient Sales Value Share by Type, 2025 VS 2032 & (%) Figure 129. Iran Immune Health Ingredient Sales Value Share by Application, 2025 VS 2032 & (%) Figure 130. Egypt Immune Health Ingredient Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 131. Egypt Immune Health Ingredient Sales Value Share by Type, 2025 VS 2032 & (%) Figure 132. Egypt Immune Health Ingredient Sales Value Share by Application, 2025 VS 2032 & (%) Figure 133. Immune Health Ingredient Value Chain Figure 134. Manufacturing Cost Structure Figure 135. Immune Health Ingredient Sales Mode & Process Figure 136. Direct Comparison with Distribution Share Figure 137. Distributors Profiles Figure 138. Years Considered Figure 139. Research Process Figure 140. Key Executives Interviewed

Scope & coverage.

Types
  • Plant & Fruit Extracts
  • Nutritional Lipids
  • Prebiotics
  • Probiotic Starter Cultures
  • Vitamins
  • Minerals
  • Enzymes
  • Functional Carbohydrates
  • Proteins
Applications
  • Beverages
  • Pharmaceuticals
  • Feed
  • Food
  • Others
Companies covered
  • ADM
  • Arla Foods
  • Associated British Foods
  • Balchem
  • Cargill
  • Chr. Hansen
  • Divis Laboratories
  • DSM
  • Glanbia PLC
  • Ingredion
  • International Flavors & Fragrances
  • Kerry Group PLC
  • MartinBauer
  • Roquette
  • ROYAL FRIESLANDCAMPINA N.V.
  • Tate & Lyle
  • BASF
  • Fonterra
  • Lonza
  • Probi

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Immune Health Ingredient Sales Value (2021-2032)
  4. 1.2.2 Global Immune Health Ingredient Sales Volume (2021-2032)
  5. 1.2.3 Global Immune Health Ingredient Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Immune Health Ingredient Market Dynamics
  1. 2.1 Immune Health Ingredient Industry Trends
  2. 2.2 Immune Health Ingredient Industry Drivers
  3. 2.3 Immune Health Ingredient Industry Opportunities and Challenges
  4. 2.4 Immune Health Ingredient Industry Restraints
3 Immune Health Ingredient Market by Company
  1. 3.1 Global Immune Health Ingredient Company Revenue Ranking in 2025
  2. 3.2 Global Immune Health Ingredient Revenue by Company (2021-2026)
  3. 3.3 Global Immune Health Ingredient Sales Volume by Company (2021-2026)
  4. 3.4 Global Immune Health Ingredient Average Price by Company (2021-2026)
  5. 3.5 Global Immune Health Ingredient Company Ranking (2024-2026)
  6. 3.6 Global Immune Health Ingredient Company Manufacturing Base and Headquarters
  7. 3.7 Global Immune Health Ingredient Company Product Type and Application
  8. 3.8 Global Immune Health Ingredient Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Immune Health Ingredient Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Immune Health Ingredient Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Immune Health Ingredient Market by Type
  1. 4.1 Immune Health Ingredient Type Introduction
  2. 4.1.1 Plant & Fruit Extracts
  3. 4.1.2 Nutritional Lipids
  4. 4.1.3 Prebiotics
  5. 4.1.4 Probiotic Starter Cultures
  6. 4.1.5 Vitamins
  7. 4.1.6 Minerals
  8. 4.1.7 Enzymes
  9. 4.1.8 Functional Carbohydrates
  10. 4.1.9 Proteins
  11. 4.2 Global Immune Health Ingredient Sales Volume by Type
  12. 4.2.1 Global Immune Health Ingredient Sales Volume by Type (2021 VS 2025 VS 2032)
  13. 4.2.2 Global Immune Health Ingredient Sales Volume by Type (2021-2032)
  14. 4.2.3 Global Immune Health Ingredient Sales Volume Share by Type (2021-2032)
  15. 4.3 Global Immune Health Ingredient Sales Value by Type
  16. 4.3.1 Global Immune Health Ingredient Sales Value by Type (2021 VS 2025 VS 2032)
  17. 4.3.2 Global Immune Health Ingredient Sales Value by Type (2021-2032)
  18. 4.3.3 Global Immune Health Ingredient Sales Value Share by Type (2021-2032)
5 Immune Health Ingredient Market by Application
  1. 5.1 Immune Health Ingredient Application Introduction
  2. 5.1.1 Beverages
  3. 5.1.2 Pharmaceuticals
  4. 5.1.3 Feed
  5. 5.1.4 Food
  6. 5.1.5 Others
  7. 5.2 Global Immune Health Ingredient Sales Volume by Application
  8. 5.2.1 Global Immune Health Ingredient Sales Volume by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Immune Health Ingredient Sales Volume by Application (2021-2032)
  10. 5.2.3 Global Immune Health Ingredient Sales Volume Share by Application (2021-2032)
  11. 5.3 Global Immune Health Ingredient Sales Value by Application
  12. 5.3.1 Global Immune Health Ingredient Sales Value by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Immune Health Ingredient Sales Value by Application (2021-2032)
  14. 5.3.3 Global Immune Health Ingredient Sales Value Share by Application (2021-2032)
6 Immune Health Ingredient Regional Sales and Value Analysis
  1. 6.1 Global Immune Health Ingredient Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Immune Health Ingredient Sales by Region (2021-2032)
  3. 6.2.1 Global Immune Health Ingredient Sales by Region: 2021-2026
  4. 6.2.2 Global Immune Health Ingredient Sales by Region (2027-2032)
  5. 6.3 Global Immune Health Ingredient Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Immune Health Ingredient Sales Value by Region (2021-2032)
  7. 6.4.1 Global Immune Health Ingredient Sales Value by Region: 2021-2026
  8. 6.4.2 Global Immune Health Ingredient Sales Value by Region (2027-2032)
  9. 6.5 Global Immune Health Ingredient Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Immune Health Ingredient Sales Value (2021-2032)
  12. 6.6.2 North America Immune Health Ingredient Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Immune Health Ingredient Sales Value (2021-2032)
  15. 6.7.2 Europe Immune Health Ingredient Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Immune Health Ingredient Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Immune Health Ingredient Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Immune Health Ingredient Sales Value (2021-2032)
  21. 6.9.2 South America Immune Health Ingredient Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Immune Health Ingredient Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Immune Health Ingredient Sales Value Share by Country, 2025 VS 2032
7 Immune Health Ingredient Country-level Sales and Value Analysis
  1. 7.1 Global Immune Health Ingredient Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Immune Health Ingredient Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Immune Health Ingredient Sales by Country (2021-2032)
  4. 7.3.1 Global Immune Health Ingredient Sales by Country (2021-2026)
  5. 7.3.2 Global Immune Health Ingredient Sales by Country (2027-2032)
  6. 7.4 Global Immune Health Ingredient Sales Value by Country (2021-2032)
  7. 7.4.1 Global Immune Health Ingredient Sales Value by Country (2021-2026)
  8. 7.4.2 Global Immune Health Ingredient Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Immune Health Ingredient Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Immune Health Ingredient Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Immune Health Ingredient Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Immune Health Ingredient Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Immune Health Ingredient Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Immune Health Ingredient Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Immune Health Ingredient Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Immune Health Ingredient Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Immune Health Ingredient Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Immune Health Ingredient Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Immune Health Ingredient Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Immune Health Ingredient Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Immune Health Ingredient Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Immune Health Ingredient Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Immune Health Ingredient Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Immune Health Ingredient Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Immune Health Ingredient Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Immune Health Ingredient Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Immune Health Ingredient Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Immune Health Ingredient Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Immune Health Ingredient Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Immune Health Ingredient Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Immune Health Ingredient Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Immune Health Ingredient Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Immune Health Ingredient Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Immune Health Ingredient Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Immune Health Ingredient Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Immune Health Ingredient Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Immune Health Ingredient Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Immune Health Ingredient Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Immune Health Ingredient Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Immune Health Ingredient Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Immune Health Ingredient Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Immune Health Ingredient Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Immune Health Ingredient Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Immune Health Ingredient Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Immune Health Ingredient Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Immune Health Ingredient Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Immune Health Ingredient Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Immune Health Ingredient Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Immune Health Ingredient Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Immune Health Ingredient Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Immune Health Ingredient Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Immune Health Ingredient Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Immune Health Ingredient Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Immune Health Ingredient Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Immune Health Ingredient Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Immune Health Ingredient Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Immune Health Ingredient Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Immune Health Ingredient Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Immune Health Ingredient Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Immune Health Ingredient Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Immune Health Ingredient Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Immune Health Ingredient Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Immune Health Ingredient Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Immune Health Ingredient Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Immune Health Ingredient Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Immune Health Ingredient Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Immune Health Ingredient Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Immune Health Ingredient Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Immune Health Ingredient Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Immune Health Ingredient Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Immune Health Ingredient Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Immune Health Ingredient Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Immune Health Ingredient Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Immune Health Ingredient Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Immune Health Ingredient Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Immune Health Ingredient Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Immune Health Ingredient Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Immune Health Ingredient Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Immune Health Ingredient Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Immune Health Ingredient Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Immune Health Ingredient Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Immune Health Ingredient Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Immune Health Ingredient Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Immune Health Ingredient Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Immune Health Ingredient Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Immune Health Ingredient Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Immune Health Ingredient Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Immune Health Ingredient Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Immune Health Ingredient Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Immune Health Ingredient Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Immune Health Ingredient Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Immune Health Ingredient Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 ADM
  2. 8.1.1 ADM Company Information
  3. 8.1.2 ADM Business Overview
  4. 8.1.3 ADM Immune Health Ingredient Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 ADM Immune Health Ingredient Product Portfolio
  6. 8.1.5 ADM Recent Developments
  7. 8.2 Arla Foods
  8. 8.2.1 Arla Foods Company Information
  9. 8.2.2 Arla Foods Business Overview
  10. 8.2.3 Arla Foods Immune Health Ingredient Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Arla Foods Immune Health Ingredient Product Portfolio
  12. 8.2.5 Arla Foods Recent Developments
  13. 8.3 Associated British Foods
  14. 8.3.1 Associated British Foods Company Information
  15. 8.3.2 Associated British Foods Business Overview
  16. 8.3.3 Associated British Foods Immune Health Ingredient Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Associated British Foods Immune Health Ingredient Product Portfolio
  18. 8.3.5 Associated British Foods Recent Developments
  19. 8.4 Balchem
  20. 8.4.1 Balchem Company Information
  21. 8.4.2 Balchem Business Overview
  22. 8.4.3 Balchem Immune Health Ingredient Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Balchem Immune Health Ingredient Product Portfolio
  24. 8.4.5 Balchem Recent Developments
  25. 8.5 Cargill
  26. 8.5.1 Cargill Company Information
  27. 8.5.2 Cargill Business Overview
  28. 8.5.3 Cargill Immune Health Ingredient Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Cargill Immune Health Ingredient Product Portfolio
  30. 8.5.5 Cargill Recent Developments
  31. 8.6 Chr. Hansen
  32. 8.6.1 Chr. Hansen Company Information
  33. 8.6.2 Chr. Hansen Business Overview
  34. 8.6.3 Chr. Hansen Immune Health Ingredient Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Chr. Hansen Immune Health Ingredient Product Portfolio
  36. 8.6.5 Chr. Hansen Recent Developments
  37. 8.7 Divis Laboratories
  38. 8.7.1 Divis Laboratories Company Information
  39. 8.7.2 Divis Laboratories Business Overview
  40. 8.7.3 Divis Laboratories Immune Health Ingredient Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Divis Laboratories Immune Health Ingredient Product Portfolio
  42. 8.7.5 Divis Laboratories Recent Developments
  43. 8.8 DSM
  44. 8.8.1 DSM Company Information
  45. 8.8.2 DSM Business Overview
  46. 8.8.3 DSM Immune Health Ingredient Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 DSM Immune Health Ingredient Product Portfolio
  48. 8.8.5 DSM Recent Developments
  49. 8.9 Glanbia PLC
  50. 8.9.1 Glanbia PLC Company Information
  51. 8.9.2 Glanbia PLC Business Overview
  52. 8.9.3 Glanbia PLC Immune Health Ingredient Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Glanbia PLC Immune Health Ingredient Product Portfolio
  54. 8.9.5 Glanbia PLC Recent Developments
  55. 8.10 Ingredion
  56. 8.10.1 Ingredion Company Information
  57. 8.10.2 Ingredion Business Overview
  58. 8.10.3 Ingredion Immune Health Ingredient Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Ingredion Immune Health Ingredient Product Portfolio
  60. 8.10.5 Ingredion Recent Developments
  61. 8.11 International Flavors & Fragrances
  62. 8.11.1 International Flavors & Fragrances Company Information
  63. 8.11.2 International Flavors & Fragrances Business Overview
  64. 8.11.3 International Flavors & Fragrances Immune Health Ingredient Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 International Flavors & Fragrances Immune Health Ingredient Product Portfolio
  66. 8.11.5 International Flavors & Fragrances Recent Developments
  67. 8.12 Kerry Group PLC
  68. 8.12.1 Kerry Group PLC Company Information
  69. 8.12.2 Kerry Group PLC Business Overview
  70. 8.12.3 Kerry Group PLC Immune Health Ingredient Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Kerry Group PLC Immune Health Ingredient Product Portfolio
  72. 8.12.5 Kerry Group PLC Recent Developments
  73. 8.13 MartinBauer
  74. 8.13.1 MartinBauer Company Information
  75. 8.13.2 MartinBauer Business Overview
  76. 8.13.3 MartinBauer Immune Health Ingredient Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 MartinBauer Immune Health Ingredient Product Portfolio
  78. 8.13.5 MartinBauer Recent Developments
  79. 8.14 Roquette
  80. 8.14.1 Roquette Company Information
  81. 8.14.2 Roquette Business Overview
  82. 8.14.3 Roquette Immune Health Ingredient Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Roquette Immune Health Ingredient Product Portfolio
  84. 8.14.5 Roquette Recent Developments
  85. 8.15 ROYAL FRIESLANDCAMPINA N.V.
  86. 8.15.1 ROYAL FRIESLANDCAMPINA N.V. Company Information
  87. 8.15.2 ROYAL FRIESLANDCAMPINA N.V. Business Overview
  88. 8.15.3 ROYAL FRIESLANDCAMPINA N.V. Immune Health Ingredient Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 ROYAL FRIESLANDCAMPINA N.V. Immune Health Ingredient Product Portfolio
  90. 8.15.5 ROYAL FRIESLANDCAMPINA N.V. Recent Developments
  91. 8.16 Tate & Lyle
  92. 8.16.1 Tate & Lyle Company Information
  93. 8.16.2 Tate & Lyle Business Overview
  94. 8.16.3 Tate & Lyle Immune Health Ingredient Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Tate & Lyle Immune Health Ingredient Product Portfolio
  96. 8.16.5 Tate & Lyle Recent Developments
  97. 8.17 BASF
  98. 8.17.1 BASF Company Information
  99. 8.17.2 BASF Business Overview
  100. 8.17.3 BASF Immune Health Ingredient Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 BASF Immune Health Ingredient Product Portfolio
  102. 8.17.5 BASF Recent Developments
  103. 8.18 Fonterra
  104. 8.18.1 Fonterra Company Information
  105. 8.18.2 Fonterra Business Overview
  106. 8.18.3 Fonterra Immune Health Ingredient Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 Fonterra Immune Health Ingredient Product Portfolio
  108. 8.18.5 Fonterra Recent Developments
  109. 8.19 Lonza
  110. 8.19.1 Lonza Company Information
  111. 8.19.2 Lonza Business Overview
  112. 8.19.3 Lonza Immune Health Ingredient Sales, Value and Gross Margin (2021-2026)
  113. 8.19.4 Lonza Immune Health Ingredient Product Portfolio
  114. 8.19.5 Lonza Recent Developments
  115. 8.20 Probi
  116. 8.20.1 Probi Company Information
  117. 8.20.2 Probi Business Overview
  118. 8.20.3 Probi Immune Health Ingredient Sales, Value and Gross Margin (2021-2026)
  119. 8.20.4 Probi Immune Health Ingredient Product Portfolio
  120. 8.20.5 Probi Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Immune Health Ingredient Value Chain Analysis
  2. 9.1.1 Immune Health Ingredient Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Immune Health Ingredient Sales Mode & Process
  6. 9.2 Immune Health Ingredient Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Immune Health Ingredient Distributors
  9. 9.2.3 Immune Health Ingredient Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst